Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Free Cash Flow Free Cash Flow Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Growth Metrics

Others

Blue Biofuels (BIOF) Gains from Investment Securities (2017)

Blue Biofuels (BIOF) has disclosed Gains from Investment Securities for 4 consecutive years, with $34.9 million as the latest value for Q4 2017.

Quarterly Gains from Investment Securities changed N/A to $34.9 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $34.9 million through Dec 2017, changed N/A year-over-year, with the annual reading at $452132.0 for FY2024, N/A changed from the prior year.
Gains from Investment Securities for Q4 2017 was $34.9 million at Blue Biofuels, up from $2.0 million in the prior quarter.
The five-year high for Gains from Investment Securities was $34.9 million in Q4 2017, with the low at $755000.0 in Q1 2014.
Average Gains from Investment Securities over 4 years is $8.2 million, with a median of $2.0 million recorded in 2015.